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BACKGROUND AND PURPOSE
The acute effects of PGE2 on bladder smooth muscle and nerves were examined to determine the origin of PGE2-induced
spontaneous rhythmic contractions.
EXPERIMENTAL APPROACH
Contraction studies, confocal Ca2+ imaging and electrophysiological recordings in strips of mouse urinary bladder were used
to differentiate the effects of PGE2 on bladder smooth muscle and efferent nerves.
KEY RESULTS
PGE2 (50 mM) increased the tone and caused phasic contractions of detrusor smooth muscle strips. Confocal Ca2+ imaging
showed that PGE2 increased the frequency of whole-cell Ca2+ transients (WCTs) (72  5%) and intracellular recordings
showed it increased the frequency of spontaneous depolarizations, from 0.31·s-1 to 0.90·s-1. Non-selective inhibition of EP
receptors using SC-51322 and AH-6809 (10 mM), or the L-type Ca2+ channel blocker nifedipine (1 mM), prevented these
phasic contractions and WCTs, and reduced the tone (by 45  7% and 59  6%, respectively). Blocking P2X1 receptors with
NF449 (10 mM) caused a small but significant reduction in the frequency of PGE2-induced phasic contractions (24  9%) and
WCTs (28  17%) but had no significant effect on spontaneous depolarizations or tone. Inhibiting muscarinic receptors with
cyclopentolate (1 mM) had no significant effect on these measures. Spontaneous WCTs became synchronous in PGE2, implying
enhanced functional coupling between neighbouring cells. However, the electrical input resistance was unchanged.
CONCLUSIONS AND IMPLICATIONS
It was concluded that depolarization alone is sufficient to explain a functional increase in intercellular coupling and the ability
of PGE2 to increase detrusor spontaneous rhythmic activity does not require parasympathetic nerves.
Abbreviations
AH-6809, 6-isopropoxy-9-xanthone-2-carboxylic acid; KO, knockout; NF449, 4,4′,4″,4-[carbonylbis(imino-5,1,3-
benzenetriyl-bis(carbonylimino))]tetrakis-1,3-benzenedisulphonic acid; sAP, spontaneous action potential; sEJP,
spontaneous excitatory junction potential; SC-51322, 8-chloro-2-[3-[(2-furanylmethyl)thio]-1-oxopropyl]-dibenz(Z)
[b,f][1,4]oxazepine-10(11H)-carboxylic acid hydrazide; SMC, smooth muscle cell; TTX, tetrodotoxin; WCT, whole-cell
Ca2+ transient
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Introduction
Prostanoids are potent and ubiquitous inflammatory
mediators. In the bladder, production of prostanoids,
particularly PGE2, is elevated in pathological conditions,
such as detrusor overactivity that follows spinal cord
injury (Masunaga et al., 2006), and bladder outlet obstruc-
tion (Schröder et al., 2004). It is likely that this associa-
tion is at least partially causative, because inhibiting COX
with indomethacin reduces the symptoms of bladder over-
activity in people with neurogenic detrusor instability
(Cardozo and Stanton, 1980). Prostanoid synthesis occurs
locally in bladder urothelium and smooth muscle. This
synthesis can be initiated by factors including stretch,
nerve stimulation, injury, exposure to ATP and other
inflammatory mediators (Dveksler et al., 1989; Khan et al.,
1998).
Prostanoids are implicated in the modulation of bladder
function (Khan et al., 1998). If PGE2 is instilled intravesi-
cally in the conscious, catheterized rat, micturition is facili-
tated and an increased basal intravesical pressure is
generated (Ishizuka et al., 1995). Similar urodynamic effects
are observed in humans; intravesical instillation of PGE2
causes detrusor overactivity, urgency and decreased bladder
capacity (Schussler, 1990). The basis for such excitatory
effects, observed in detrusor strips of animal models and
humans (Maggi, 1992) is likely to be a slow increase in
detrusor muscle tone, followed by an increase in phasic
contractions (Bultitude et al., 1976). These PG-generated
smooth muscle contractions are inhibited by the L-type
calcium channel blocker verapamil (Hanawa, 1991; cited in
Khan et al., 1998).
PGE2 is likely to mediate its effects through more
than one EP receptor. The competitive EP1 antagonist
SC-19220 increases bladder capacity and reduces voiding
efficiency in anaesthetized rats (Maggi et al., 1988). Recent
studies in EP1 knockout (KO) mice have shown that PGE2 is
not essential for normal micturition but does play a role in
detrusor overactivity (Schröder et al., 2004). Studies using EP
receptor KO mice suggest a role for EP1 in detrusor overac-
tivity (Schröder et al., 2004), whereas EP3 is implicated in
bladder capacity in physiology (McCafferty et al., 2008).
Further experiments are required to characterize the role of
different EP receptors in physiological and pathophysiologi-
cal conditions.
It is still unclear whether PGE2 mediates its actions in
the bladder directly on smooth muscle cells (SMCs) or indi-
rectly by acting on nerves. It has been suggested that PGs
released from SMCs and from the urothelium modulate
afferent nerve activity and efferent neurotransmission
(de Groat and Yoshimura, 2001). Furthermore, our group
recently showed that spontaneous action potentials (sAPs)
in mouse bladder are purinergic and neurogenic (Young
et al., 2008), suggesting that if PGE2 affects spontaneous
activity it could do so through a direct action on efferent
nerves.
Hence, the aim of this study was to differentiate the
effects of PGE2 on bladder smooth muscle and efferent nerves
using a combination of contraction studies, high-resolution
Ca2+-imaging and electrophysiology.
Methods
Female CD-1 mice, aged 8–13 weeks, were killed by increasing
the CO2 concentration followed by cervical dislocation. All
experiments were carried out in accordance with the UK
Animals (Scientific Procedures) Act 1986 and European Com-
munities Council Directive 86/09/EEC. The urinary bladder
was removed and placed in physiological saline. The bathing
physiological salt solution contained (mM): NaCl 118.4,
NaHCO3 25.0, NaH2PO4 1.13, CaCl2 1.8, KCl 4.7, MgCl2 1.3
and glucose 11.1. pH and [O2] were regulated by continuously
bubbling the solution reservoir with 95%O2 and 5% CO2. The
connective tissue surrounding the bladder was first removed,
then the ventral wall of the bladder was opened longitudi-
nally from the bladder neck to the apex of the dome. The
urothelium was left intact. Tissue strips, 6–8 mm long and
1–2 mm wide, were cut along the craniocaudal axis of the
dorsal surface for organ bath studies and were 3–4 mm long
and 1–2 mm wide for electrophysiological recording or Ca2+
imaging.
Contraction studies
Each bladder strip was mounted in a 7 mL organ bath and
connected to an isometric transducer (Letica Scientific Instru-
ments, Hospitalet, Spain), under an initial tension of 9.8 mN
and allowed to equilibrate (i.e. to accommodate under
tension) for at least 60 min. Contraction data were digitized
using a Powerlab/4SP data acquisition system, Chart v.5.5.6/s
software (ADInstruments, Chalgrove, UK) and data stored on
a Macintosh computer. The maximum amplitude of contrac-
tions was measured off-line.
Electrophysiological recordings
Bladder strips were allowed to equilibrate for at least 30 min,
and then individual bladder SMCs were impaled from the
serosal surface using a shallow angle of approach and super-
ficial penetration with glass capillary microelectrodes filled
with 0.5 M KCl (resistance 200–300 MW). This approach is
identical to that used previously in our laboratory (Young
et al., 2008), where filling the cells with Oregon Green 488
BAPTA-1 (mixed with the KCl in the microelectrode) showed
large cells typical of SMCs (Dixon and Gosling, 1990; Ander-
sson and Arner, 2004). For both electrophysiology and Ca2+
imaging, pinning with a small amount of even stretch
reduced most spontaneous movement of detrusor strips. The
use of long-tipped electrodes assisted the maintenance of
recordings during movement of the tissue, a particular meth-
odological challenge when using PGE2. Following bridge bal-
ancing and neutralization of the electrode’s tip capacitance,
membrane potential changes were recorded using a high
input impedance amplifier (Axoclamp-2B; Axon Instruments,
Sunnyvale, CA, USA) and displayed on a digital oscilloscope
(DSO 1602; Gould, Ilford, Essex, UK). Membrane potential
changes were digitized at 1 kHz using a PowerLab/4SP (ADIn-
struments, Chalgrove, Oxfordshire, UK) and stored on com-
puter for later analysis.
One long, continuous recording per preparation was
made, which included a control period (typically 10 min),
and then a period (at least 15 min) in the presence of the
drug. The approach of making a single recording per prepa-
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ration, rather than sampling several SMCs in control condi-
tions and then several SMCs following perfusion of a drug,
was favoured as the PGE2-induced contractions greatly hin-
dered subsequent impalement of further SMCs.
The electrical properties of mouse detrusor smooth
muscles were determined by passing outward current (in
steps of -0.03 to -0.15 nA, of 100 ms duration) through the
recording microelectrode.
To determine the frequency with which bursts of sponta-
neous depolarizations occurred following PGE2 superfusion,
recording segments in which such bursts were present were
assessed. The membrane potential was low-pass filtered (0.1
to 0.5 Hz cut-off frequency) and a correlation coefficient of
this channel to a typical low-pass filtered burst (template) was
calculated. Bursts were then defined using the ‘cycle vari-
ables’ function, with the noise threshold (10 to 40%) adjusted
until it provided specificity comparable to manual counting
of such bursts in unfiltered data (Chart; ADInstruments,
Chalgrove, Oxfordshire, UK).
Ca2+ imaging and analysis
Each detrusor strip was exposed to 10 mM Oregon Green 488
BAPTA 1-AM (Invitrogen, Paisley, UK) in 1% DMSO-0.2%
Pluronic F-127 (Sigma-Aldrich, Dorset, England) in physi-
ological saline for 70 min at 36°C. The tissue was rinsed in
physiological saline, bubbled with 95%O2/5%CO2 to pH 7.4,
for at least 10 min. Tissues were pinned flat, serosal side up, in
a Sylgard-lined organ bath, and mounted on the stage of an
upright confocal microscope (Leica SP2; Leica Microsystems,
Milton Keynes, UK). A series of 70 frames was captured at
5 Hz using a ¥40 objective to generate one image set. Such
sets were acquired once every minute. Five sets were sampled
for control and drug treatments within one region, contain-
ing a minimum of two cells sampled per drug or treatment.
Image analysis was performed using custom-written macros
for Image SXM v1.85 (http://www.liv.ac.uk/~sdb/ImageSXM).
Data were exported to Chart v5.5.6 and then to Excel
(Microsoft, Redmond, WA, USA) for further analysis.
Correlating whole-cell Ca2+ transients between
neighbouring cells
The total number of whole-cell Ca2+ transients (WCTs)
observed in neighbouring cells, before and after superfusion
with PGE2 (50 mM) was compared. Only directly neighbour-
ing cells that exhibited WCTs under control conditions were
analysed. Contingency analysis (with Fisher’s exact test) was
used to determine whether cells were functionally coupled.
Drugs
All drugs were stored at -20°C as 10 mM stock solutions; PGE2
and SC-51322 in ethanol, nifedipine and AH-6809 in DMSO,
andNF449, tetrodotoxin (TTX) and cyclopentolate in distilled
water. Nifedipine and cyclopentolate hydrochloride were
obtained from Sigma (Dorset, UK); SC-513322 and AH 6809
were obtained from Biomol (Exeter, UK); and PGE2, TTX and
NF449 were obtained from Tocris (Bristol, UK). Drugs were
diluted to their final concentration with physiological saline
and applied directly into the relevant baths in the contraction
studies, and by switching the superfusate in the Ca2+-imaging
and electrophysiological experiments. Themaximum ethanol
concentration used was relatively high, so particular attention
was paid to these control experiments. In physiological saline,
0.5% ethanol did not produce a change in either the tone, the
phasic contractions in any of the 12 preparations tested
(number of animals, na = 9), the WCTs (number of prepara-
tions, np = 9, na = 3), resting membrane potential (median
-43.5 mV; range -48.5 to -32.7 mV; to median -42.3 mV;
range -50.2 to -31.9 mV), or the amplitude of spontaneous
depolarizations (median 4.2 mV; range 3.4 to 6.0 mV; to
4.0 mV; range 3.2 to 5.0 mV; P = NS). The nomenclature of
receptors and ion channels conforms to BJP’s Guide to Recep-
tors and Channels (Alexander et al., 2011).
Statistical analysis
The normality and homogeneity of variance were tested prior
to further statistical analysis using Kolmogorov–Smirnov and
Levene’s tests, respectively (SPSS version 11; SPSS Inc.,
Chicago, IL, USA). Other statistical analyses were performed
in Prism 4 (GraphPad Software, CA, USA). Unless otherwise
stated, statistical comparisons were by Student’s two-tailed
paired t-tests. The term na, used in the presentation of statis-
tical analyses throughout, refers to the number of animals
used and the term np refers to the number of preparations
used. To test for functional coupling between nearby cells,
contingency tables were constructed and tested with Fisher’s
exact test (for a methodological example, see Brain et al.,
2002).
Results
Contraction studies
On mouse isolated bladder strips, PGE2 (50 mM) caused a
concentration-dependent increase in tone with an EC50 of
9.2 mM (pEC50 = 5.04  0.41; Figure 1A; np = 11; na = 6). The
tone developed slowly (Figure 1B; median time to plateau:
56 s; range 41–160 s; np = 20, na = 10) and rapid phasic con-
tractions were superimposed. The basal tone increased from
2.26 0.33 mN to 4.51 0.32 mN (P < 0.001, np = 20, na = 10;
Figure 1C). After stabilization of the tone, the rapid changes
in tension continued until washout, although a reduction in
frequency was observed 12–15 min after the application of
PGE2 (50 mM) (by 40.4 3.1%, np = 14, na = 7). Only five strips
showed phasic contractions under control conditions and the
average frequency was increased by PGE2 (from 0.042 
0.016·s-1 to 0.24 0.02·s-1; P < 0.01, np = 15, na = 8; Figure 1D).
To determine whether part of this response could be
driven by an action on efferent parasympathetic nerves, the
effects of the Na+ channel blocker TTX and the N-type Ca2+
channel blocker w-conotoxin GVIA were investigated. TTX
(1 mM) did not affect the increase in basal tone observed
after addition of PGE2 (50 mM) (relative change of 5.3  5.5%
compared with PGE2 alone; P = NS, np = 8, na = 6), nor the
frequency of phasic contractions (14 15%), nor their ampli-
tude (14  9%). Similarly, w-conotoxin GVIA (100 nM) pre-
treatment had no significant effect on PGE2-induced changes
in basal tone (15  8%; P = NS, np = 8, na = 6). Phasic
contraction frequency (4.3  3.5%, P = NS, np = 8, na = 6) and
amplitude (9.1  7.8%, P = NS, np = 8, na = 6) were also not
significantly affected.
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To determine whether L-type Ca2+ channels were required
for the response to PGE2 (50 mM), the selective L-type Ca2+
channel blocker nifedipine (1 mM) was used. Nifedipine
reduced the increase in basal tone observed after addition of
PGE2 (50 mM) by 45.3  6.6% (P < 0.05, np = 20, na = 10) and
abolished the PGE2-induced phasic contractions in all prepa-
rations (Figure 2Aa). To determine whether neurotransmitter
release mediated PGE2-induced contractions, the contribu-
tions of purinergic and cholinergic neurotransmission were
explored by application of the P2X1 selective antagonist
NF449 (10 mM) or the muscarinic receptor antagonist cyclo-
pentolate (1 mM). The P2X1 selective antagonist NF449
(10 mM) did not significantly affect the PGE2 (50 mM)-induced
tone (8.4  12.4%, P = NS, np = 15, na = 9), but significantly
reduced the frequency of phasic contractions (by 23.5 
8.5%, P < 0.05, np = 6, na = 4; Figure 2Ab). Cyclopentolate
pretreatment had no effect on the PGE2-induced tone (15 
18% P = NS, np = 8, na = 4) or on the frequency of phasic
contractions (0.4  2.4%, P = NS, np = 7, na = 4; Figure 2Ac).
In order to identify the role of EP receptors in the
response to PGE2 (50 mM), SC-51322 (10 mM), a selective EP1
antagonist, and AH-6809 (10 mM), a non-selective EP2 and EP3
antagonist were used (Figure 2Ad). The binding affinity for
SC-51322 is 14 nM for EP1 receptors, and AH-6809 has a Ki of
1.1–1.6 mM at EP1–3 receptors (Abramovitz et al., 2000); so,
both of these antagonists were used at concentrations signifi-
cantly in excess of their Ki and/or binding affinity. When used
together a significant reduction in the PGE2 (50 mM)-induced
tone was observed (by 59.2  6.2%, P < 0.01, np = 6, na = 6)
and phasic contractions did not occur. When used separately
SC-51322 and AH-6809 significantly reduced the PGE2
(50 mM)-induced tone, but to a lesser extent (by 39.1  5.8%
P < 0.05, np = 7, na = 6 and 23.7  4.4% P < 0.05, np = 5, na =
5, respectively) suggesting an additive effect of the two
antagonists. The frequency of phasic contractions was signifi-
cantly reduced by SC-51322 (64  38% P < 0.05, np = 7, na =
6), but not by AH-6809 alone (9.7  4.7% P = NS, np = 5, na =
5). The effects of these antagonists on tone and the frequency
of phasic contractions are summarized in Figure 2B and C,
respectively.
Electrophysiology
Electrophysiological studies were used to characterize the
electrical changes in response to PGE2 (50 mM). Spontaneous
depolarizations, i.e. both spontaneous excitatory junction
potentials (sEJPs) and sAPs, occurred with a stochastic tem-
poral distribution in control conditions, but occurred in
bursts following the superfusion of PGE2 (50 mM; Figure 3).
Bursting began following superfusion for 350 s (median;
range 161 to 629 s; na = 11). Bursts of spontaneous depolar-
izations occurred at a frequency of 0.14  0.02 Hz (mean 
SEM; range 0.08 to 0.22 Hz, no. of bursts 10–138 from na =
10). One way of showing that the spontaneous depolariza-
tions occur in bursts is to measure the interval between suc-
cessive events; if these events occur independently then the
probability density function for such intervals should be
exponential. This distribution of intervals between successive
depolarizations in control conditions was exponential, but in
the presence of PGE2 events with a short (<2 s) interval
occurred with a greater probability than expected (Figure 4A),
implying that they were clustered in bursts.
PGE2 (50 mM) increased the frequency of spontaneous
depolarizations from 0.31 Hz (median; range 0.18 to 0.75 Hz)
to 0.90 Hz (range 0.40 to 1.41 Hz; two-tailed paired t-test, P <
0.001, np = 13, na = 12; Figure 4Ba). This is in contrast to the
solvent (0.5% ethanol) control, which actually reduced the
frequency of spontaneous depolarizations from 0.36 Hz
(median; range 0.14 to 0.51 Hz) to 0.29 Hz (range 0.10 to
0.44 Hz) (P < 0.001). PGE2 (50 mM) also depolarized the
resting membrane potential from -43.9 mV (median; range
Figure 1
Exogenously applied PGE2 contracts the murine urinary bladder strips
in a concentration-dependent manner (A; np = 11, na = 6) with an
EC50 of 9.2 mM. (B) A sample trace of the effects of PGE2 (50 mM) on
such a muscle strip (np = 20, na = 10). The increase in tone is followed
by phasic activity. PGE2 (50 mM) increased tone (C; np = 20, na = 10)
and the frequency of phasic contractions (D; np = 14, na = 7). **P <
0.01 and ***P < 0.001, compared to control.
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-50.2 to -24.6 mV) to -33.3 mV (range -41.2 to -16.1 mV)
(P < 0.001; Figure 4Bb). In control conditions, depolarizations
occurred with variable rise time (time from 10 to 90% peak
amplitude) with a median of 18.8 ms (range 7.4 to 66.0 ms).
Following superfusion of PGE2 (50 mM), the resulting sponta-
neous depolarizations occurred with a much broader rising
phase, that is, with a greater rise time of 39.3 ms (range
20.8 to 98.5 ms) (P < 0.001; Figures 3C, 4Bc). The median
amplitude of depolarizations increased from 4.0 mV (median;
range 3.0 to 10.7 mV) in control conditions to 5.0 mV
(4.5 to 16.7 mV) in the presence of PGE2 (50 mM) (P < 0.05;
Figure 4Bd).
In order to test whether the effects of PGE2 were mediated
through P2X1 receptors, PGE2 (50 mM) was superfused in
combination with the selective P2X1 antagonist NF449
(10 mM). Pretreatment with NF449 (10 mM) did not change
the amplitude, frequency or interval between spontaneous
depolarizations, nor did it prevent the change in the resting
membrane potential, in response to PGE2 (50 mM) (Figure 5A;
Table 1). There was, however, an increase in the rise time of
events from 47.7 ms with PGE2 (50 mM) alone to 67.4 ms
when NF449 (10 mM) was also present (P < 0.05).
The L-type Ca2+ channel antagonist nifedipine (1 mM)
prevented all measured effects of PGE2 on spontaneous
depolarizations, but the PGE2-stimulated change in resting
membrane potential remained (Figure 5B; Table 2).
Ca2+ imaging
Ca2+-imaging was used to determine the effect of PGE2
(50 mM) on smooth muscle Ca2+ regulation, particularly
WCTs. Previous studies have shown that WCTs are due to
smooth muscle action potentials (Heppner et al., 2005; Young
et al., 2008).
Loading detrusor smooth muscle with the Ca2+ indicator
Oregon Green BAPTA-1 AM and imaging groups of smooth
muscle under control conditions revealed three types of
spontaneous Ca2+ transients: WCTs, Ca2+ waves and local Ca2+
transients. Only WCT frequency and amplitude were inves-
tigated in this study.
WCTs were present under control conditions and their
frequency was increased significantly by PGE2 (50 mM) (by 72
 5%; P < 0.001, np = 27 cells, na = 9; Figure 6A,B). PGE2
(50 mM) also appeared to increase the occurrence of subcellu-
lar Ca2+ transients, including waves (see Figure S1), although
the frequency was not calculated. The amplitude of the WCTs
was not affected by PGE2 (0.340  0.031 DF/F0 under control
conditions; 0.300  0.025 DF/F0 after PGE2 superfusion; P =
NS; Figure 6C). The Ca2+ channel blocker nifedipine (1 mM)
Figure 2
L-type Ca2+ channels and EP receptors mediate PGE2-induced phasic contractions. (A) A comparison of the effects of the superfusion of the selective
L-type Ca2+ channel blocker nifedipine (1 mM; a), the P2X1 receptor antagonist NF449 (10 mM; b), the muscarinic receptor antagonist
cyclopentolate (1 mM; CP; c) and a combination of the selective EP1 receptor antagonist SC-51322 (10 mM) and the non-selective EP2 and EP3
receptor antagonist AH-6809 (10 mM; d). The black trace shows a matching control trace (i.e. without any antagonist present), while the grey
trace shows the response in the presence of the relevant antagonist(s). (B) A comparison of the change in tone for each drug application to
normalized control frequencies; Student’s paired t-test was used for the comparisons. The effect of each drug on the frequency of phasic activity
was also assessed (C). *P < 0.05.
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prevented PGE2-induced WCTs (11 cells, na = 4; Figure 7A). In
the absence of PGE2, incubation with the selective P2X1
antagonist NF449 (10 mM) greatly reduced the frequency of
WCTs (by 98  6%; P < 0.001, two-way ANOVA, np = 18 cells,
na = 4). Upon addition of PGE2 (50 mM) in the presence of the
NF449 (10 mM), WCTs were observed but at a significantly
lower frequency than with PGE2 alone (by 28  17%; P <
0.001, two-way ANOVA; Figure 7B,C).
PGE2 and cellular coupling
PGE2 (50 mM) superfusion increased the frequency of WCTs,
but also nearby cells responded synchronously. To deter-
mine if such apparent synchronicity was random, contin-
gency tables were used to compare the number of times
the cells responded separately against the number of times
the cells responded together. In two of five pairs of cells
tested there was a significant synchronous activity of WCTs
after PGE2 (50 mM) addition compared to no significant
synchronous activity under control conditions for these
same pairs (P < 0.001; Fisher’s exact test; see Figure 8A and
Figure S2).
Figure 3
Superfusion of PGE2 (50 mM) depolarizes SMCs and induces bursts of
spontaneous depolarizations. (A) Over a period of 18 min, PGE2
(50 mM) depolarized the resting membrane potential of a SMC
within a strip of mouse isolated detrusor. (B) A comparison of the
spontaneous activity prior to (Ba) and during (Bb) PGE2 superfusion;
PGE2 stimulated the large amplitude spontaneous depolarizations
that occur in bursts. (C) Shows the PGE2-stimulated spontaneous
depolarizations have slow rise times.
Figure 4
The distribution of intervals between successive spontaneous depo-
larizations (Aa) demonstrates that under control conditions they
occur randomly, as the control distribution (solid line, black) follows
the expected exponential distribution (dashed line, black). In the
presence of PGE2 (50 mM), bursting occurs, shown by the excess of
brief intervals compared with the expected exponential distribution
(compare the dashed and solid grey lines). (Ab) The median intervals
were also briefer in the presence of PGE2. (B) PGE2 also stimulated an
increase in spontaneous depolarization frequency (a), an increase in
rise time (c) and amplitude (d), and a depolarization of the RMP of
SMCs (b). The data were obtained from np = 13 and na = 12 (Ab, B);
*P < 0.05 and ***P < 0.001.
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To determine whether there was an effect of PGE2 (50 mM)
or its vehicle (0.5% ethanol) on electrical coupling between
mouse detrusor SMCs, a series of brief intracellular current
injections (-0.03 to -0.15 nA of 100 ms duration) was
applied. Input resistances, calculated from the linear slope of
the current–voltage relationship, varied greatly between
SMCs. However, there was no significant difference between
the input resistance of SMCs in control conditions, 212 MW
(median; range 115 to 660 MW) and following superfusion of
the vehicle (0.5% ethanol; 168 MW; range 84 to 769 MW;
Wilcoxon matched two-tailed pairs test, P = NS, na = 5).
Similarly, PGE2 (50 mM) did not change the input resistance
(median control 181 MW; range 115 to 1060; PGE2 median
209 MW; range 98 to 1045; Wilcoxon matched two-tailed
pairs test, P = NS, na = 6).
Discussion and conclusions
In the urinary bladder, PGE2 is implicated in physiological
and pathophysiological conditions (Khan et al., 1999;
Schröder et al., 2004; Masunaga et al., 2006). Previous studies
have shown that PGE2 causes bladder overactivity when
instilled intravesically (Schussler, 1990; Lee et al., 2008) and
causes contraction of isolated bladder tissue (Palea et al.,
1998). However, it is unclear whether PG’s effects are neu-
ronal or on the SMCs themselves, an issue the present study
addresses.
PGE2 (50 mM)-induced activity included an increased fre-
quency of phasic contractions (85% increase), increased fre-
quency of WCTs (72% increase) and a 66% increase in
spontaneous depolarizations. To the authors’ knowledge, this
is the first study to show cellular electrical and Ca2+ responses
to PGE2 in the bladder.
Figure 5
PGE2 (50 mM)-induced bursts of spontaneous depolarizations are
mediated by L-type Ca2+ channels and not P2X1 receptors. (A) The
P2X1 receptor antagonist NF449 (1 mM) did not affect the occur-
rence of PGE2 (50 mM)-induced bursts of spontaneous depolariza-
tions. (B) The occurrence of these events was abolished by the L-type
Ca2+ channel antagonist nifedipine (1 mM).
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Not all of the tissue strips displayed clear phasic con-
tractions under control conditions, which may be due to
different sensitivity to stretch, receptor subtype spatial in-
homogeneity or other unidentified sources of variability
amongst preparations.
PGE2-induced phasic contractions are
mediated by L-type Ca2+ channels
and EP receptors
Previous studies on mouse and rat urinary bladder have
implicated both EP1 and EP3 receptors in PGE2-induced
bladder overactivity. PF-2907617-02 and SC-19220, selective
EP1 antagonists, increased bladder capacity in normal rat
bladders, but did not identify a necessary role of EP1 recep-
tors in normal micturition (Maggi et al., 1988; Lee et al.,
2007). Thus it has been suggested that EP1 receptors stimu-
late physiological effects during the storage phase but not
during the voiding phase of micturition (Lee et al., 2007).
Cystometry on EP1 KO mice supported the idea that EP1
receptor function is not required for normal micturition
(Maggi et al., 1988). However, the PGE2-induced overactivity
observed in rats was blocked by PF-2907617-02 in a dose-
dependent manner (Lee et al., 2007), and PGE2-induced
overactivity in mice only occurred in wild-type (WT) EP1
mice and not in KO EP1 mice, implicating the EP1 receptor
directly with overactivity (Maggi et al., 1988). In our experi-
ments, blocking EP1 receptors with SC-51322, which is
effective in rodents (Moreland et al., 2003), reduced the
PGE2-induced frequency of phasic contractions (64% reduc-
tion) and decreased the change in tone observed after PGE2
addition (39% reduction).
Other studies have implicated EP3 receptors as mediators
of PGE2-induced bladder overactivity. Infusion of PGE2 into
WT mice induced bladder overactivity, an effect that was
not present in EP3 KO mice. Furthermore, EP3 KO mice
had an enhanced bladder capacity compared to WT mice,
therefore associating EP3 receptors with normal bladder
physiology (McCafferty et al., 2008). In our experiments,
non-selective EP2 and EP3 antagonism using AH-6809 caused
a significant decrease in the change of tone induced by
PGE2 (50 mM) (23.7  4.4%). However, AH-6809 did not
significantly affect the frequency of phasic contractions
observed after PGE2 (50 mM) addition (9.7  4.7%). The
effect of SC-51322 and AH-6809 (both 10 mM) were additive
for an effect on tone after PGE2 (50 mM) addition. The PGE2-
induced increase in the frequency of phasic contractions
was also abolished in all preparations in the presence of
both antagonists. Thus, in order to reduce the PGE2-induced
phasic contractions, blocking EP1 receptors is necessary, but
in order to prevent these phasic contractions all EP recep-
tors present must be blocked. The change in tone could not
be abolished with non-selective EP receptor antagonism,
suggesting the involvement of another mechanism or that
the antagonist concentration was insufficient to overcome
an agonist concentration of about five times greater than
the EC50 (50 mM compared with 9.2 mM). Alternatively, deg-
radation of PGE2 by 15-hydroxyprostaglandin dehydroge-
nase, which is known to be expressed by urothelial cells
(Tseng-Rogenski et al., 2008), might initiate a catabolic
cascade of which some members may be active.
In our studies, we found that blocking L-type Ca2+ chan-
nels with nifedipine abolished all PGE2-induced phasic con-
tractions, WCTs and sAPs. In addition, it reduced the change
in tone observed after PGE2 addition by 45.3  6.6%. This
indicates that PGE2-induced phasic contractions require
smooth muscle L-type Ca2+ channels and EP receptors on
smooth muscle or other nearby cells. Previous studies using
the L-type Ca2+ channel antagonist verapamil showed
similar effects on contraction (Morita et al., 1994); together,
these findings suggest that PGE2 acts to increase Ca2+ influx
into the cell. There is evidence that the signal transduction
of EP1 involves extracellular Ca2+ entry through a pathway
independent of phospholipase C activation (Katoh et al.,
1995). Given the PGE2-induced depolarization we now
report, it seems that this slow depolarization causes bursts
of L-type Ca2+ channel-dependent smooth muscle action
potentials. The remaining questions are how such a slow
depolarization is initiated by PGE2 and how the residual
contraction observed on blocking L-type Ca2+ channels is
mediated.
Table 2
The effects of PGE2 (50 mM) and the L-type Ca2+ channel antagonist nifedipine (1 mM) on properties of SMCs and their spontaneous depolar-
izations (sDep)
Control
PGE2 (50 mM) +
nifedipine (1 mM) P
RMP (mV) -43.8 [-60.7 to -36.5] -33.5 [-55.8 to -24.9] <0.01
sDep
Frequency (Hz) 0.3 [0.1–0.7] 0.2 [0.0–0.6] NS (0.29)
Amplitude (mV) 4.7 [3.3–5.4] 3.9 [3.4–5.4] NS (0.08)
Interval (s) 2.6 [1.1–6.3] 2.9 [1.1–7.2] NS (0.11)
Rise time (ms) 19 [12–25] 18 [9–21] NS (0.29)
No. events 301 [148–2602] 569 [102–688]
na 7 7
Data shown are median [range]. na, number of animals. NS denotes P > 0.05.
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PGE2-induced phasic contractions are
not neurogenic
There is evidence for EP3 receptors on some cholinergic
parasympathetic nerve terminals (Reinheimer et al., 1998;
Spicuzza et al., 1998), facilitation of parasympathetic neu-
rotransmitter release through EP1 receptors (Jadhav et al.,
2009) and direct depolarization of intrinsic cardiac neurons
by PGE2 through SKCa channel inhibition (Jelson et al., 2003).
All of these findings led to the suggestion that PGE2 induces
similar facilitatory effects in the urinary bladder. However,
none of the observed effects of PGE2 in the mouse bladder
were prevented by TTX, which is known to abolish field-
stimulation-induced contraction in the mouse bladder (Holt
et al., 1985), indicating that action potential generation in
efferent nerves was not required. This observation is consis-
Figure 6
PGE2 increases the frequency of WCTs, but not their amplitude. (A) A
sample trace of the frequency of WCTs. This trace is a concatenated
composite of shorter 19.8 s recording segments taken every minute.
The scale bar indicates the time over the whole experiment so is not
valid within each segment. The trace shows the presence of WCTs
under control conditions and after addition of PGE2 (50 mM). The
positive-going spikes on the trace are WCTs, shown throughout the
course of an experiment for a typical preparation; slow changes in
the baseline represent focal plane drift while imaging and are hence
an artefact of this non-ratioable Ca2+ indicator. (B) The effect of PGE2
(50 mM) on WCT frequency. (C) The effect of PGE2 (50 mM) on WCT
amplitude. **P < 0.01.
Figure 7
PGE2-induced increase in frequency of WCTs is abolished by nife-
dipine and reduced by NF449. (A) WCTs after the addition of PGE2
(50 mM) alone and in the presence of nifedipine (1 mM). The spikes
on the trace represent WCTs, against time, in one preparation. (B)
The frequency of WCTs after superfusion with PGE2 (50 mM) in the
presence and absence of NF449 (10 mM). Each trace is a concat-
enated composite of shorter 13.7 s recording segments taken every
minute. (C) A comparison of the frequency of WCTs under different
conditions. *P < 0.05 and **P < 0.01.
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tent with experiments in human bladder strips, demonstrat-
ing that the response to PGE2 is insensitive to TTX (Andersson
et al., 1977). Additionally, the failure of w-conotoxin GVIA to
inhibit the response also contravenes the idea that local
depolarization of the nerve terminals triggers local nerve
terminal Ca2+ influx and transmitter release, although it is
acknowledged that some voltage-gated Ca2+ channel subtypes
other than N-type Ca2+ channels can contribute to parasym-
pathetic transmission in the mouse bladder (Waterman,
1996).
In the normal mouse bladder spontaneous depolariza-
tions and sAPs result from nerve-released ATP acting on P2X1
receptors (Meng et al., 2008; Young et al., 2008), although
under other experimental conditions there may also be spon-
taneous activity that is purely myogenic (Hayase et al., 2009).
The first biophysical indication that PGE2-induced depolar-
izations are induced in a different manner to the normal sEJPs
and sAPs was the difference in their electrical properties, such
as a slower rise time (Table 1). We found that NF449 alone
abolished sEJPs, sAPs and WCTs (confirming the earlier obser-
vations of our group; Young et al., 2008), yet PGE2 was still
able to initiate similar events, albeit with a lower frequency of
WCTs (by 28  17%) and phasic contractions (by 23.5 
8.5%). Interestingly, the reduction in the frequency of PGE2-
induced WCTs observed in the presence of NF449 (to 0.050 
0.009 Hz) is similar to the control frequency of WCTs (0.053
 0.027 Hz). While PGE2-induced spontaneous depolariza-
tions were not affected by NF449 (Table 2), we feel that this
represents a lack of statistical power (n = 4 cells) in this
technically demanding set of experiments. Also, PGE2-
induced phasic contractions in the presence of NF449 were
reduced (to 0.103  0.065 Hz) to a level similar to the control
frequency of phasic contractions (0.062  0.044 Hz). Overall,
these data suggest that pretreatment with NF449 reduces
basal neurogenic, purinergic activity but not the PGE2-
induced activity. PGE2-induced phasic contractions were
insensitive to the muscarinic antagonist cyclopentolate
(1 mM). These results argue against both direct and indirect
effects of PGE2 on parasympathetic nerves innervating the
urinary bladder, suggesting a direct action on the smooth
muscle or other nearby cells.
PGE2 induces bursts of spontaneous activity
The synchronicity of WCTs in the presence of PGE2 led to the
investigation of whether PGE2 increased electrical coupling
between the cells. However, no significant fall in the input
resistance (which represents a mixture of membrane resis-
tance and gap junction resistance) was observed. It seems
likely that the SMCs become functionally coupled not
because of changes in gap junction resistance, but because of
their depolarization. As cells depolarize (in this case by
11 mV), they move closer to their threshold for action poten-
tial initiation and hence require less depolarizing current to
flow from adjacent active cells in order to initiate and propa-
gate action potentials. In this way, depolarization directly
increases functional action potential coupling, and hence
co-ordinates micromotion or phasic contractions, without
any change in the electrical resistance between cells.
K+ channel inhibition may be responsible for the depolar-
ization and the shift from stochastic action potential occur-
rence to bursting observed in the current study, similar to
that observed in the guinea-pig bladder when small conduc-
tance Ca2+-activated K+ (SK) channels are inhibited with
apamin (Hashitani et al., 2004a). In the mouse urinary
bladder, apamin can increase the frequency of spontaneous
depolarizations without changing the resting membrane
potential (Hayase et al., 2009), while suppression of SK chan-
nels in mice increases the frequency of non-voiding contrac-
Figure 8
WCTs occur simultaneously across multiple neighbouring smooth
muscle cells in the presence of PGE2. (A) A region of a mouse isolated
bladder detrusor (loaded with the Ca2+ indicator Oregon Green 488
BAPTA-1 AM) showing four smooth muscle cells (denoted by aster-
isks). Time frames are 198 ms apart, arranged horizontally. The total
number of frames sampled was 350. All cells responded to PGE2 and
the cells labelled a and b were analysed to test if the probability of a
WCT occurring synchronously in both cells was increased after PGE2
addition. (B) The frequency of synchronous and asynchronous WCTs
under control conditions and after the addition of PGE2. *P < 0.05
(contingency tables and Fisher’s exact test). Only in the presence of
PGE2 were synchronous WCTs detected at a rate greater than that
predicted by chance.
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tions (Herrera et al., 2003). Kv channels might also be
involved; tetraethylammonium (TEA; 10 mM) acutely depo-
larizes mouse bladder SMCs (Hayase et al., 2009), suppresses
after-hyperpolarizations, and increases sAP frequency,
although this effect was lost over time at that high concen-
tration of TEA. WCTs also became more synchronous in TEA.
So, although several K+ channels might be involved, inhibi-
tion of the TEA-sensitive (i.e. Kv) channel most readily
explains the effects of PGE2, although this was not directly
tested.
Chloride channel activation by PGE2 cannot be ruled out,
because PGE2-induced Cl- channel activation has been shown
in some other cell types (Okamoto et al., 2004; Seto et al.,
2008). However, the driving force for Cl- is much smaller
than that for K+, so a much larger change in Cl- conductance
would be needed in order to explain any given depolariza-
tion. Given that a significant change in input resistance was
not detected (median change from 181 to 209 MW), it seems
unlikely that such a large fall in membrane resistance
occurred.
Interstitial cells and the role of PGs
Interstitial cells of Cajal (ICCs) are of great contemporary
interest in urogenital physiology because of the close associa-
tion of the cells with SMCs and nerves, and because of the
presence of a large suburothelial plexus in the lamina propria
(Brading and McCloskey, 2005). During the present study we
were unable to identify cells with a morphology typical of
ICCs, which responded to PGs with a change in Ca2+,
although quiescent cells with this morphology were observed
in some series (see Figure S3 for an example). The experimen-
tal protocol was not optimized to investigate such cells, in
part because viewing from the serosal side means that the
lamina propria layer of ICCs (ICC-LP) cannot be seen. The
more scattered detrusor ICCs, typically located at the edge of
muscle bundles (see McCloskey, 2010 for a review) are diffi-
cult to differentiate morphologically from both Schwann
cells and fibroblasts, and this study was adequately designed
appropriately to study these cells. A vital staining method for
ICCs would greatly facilitate such experiments. Thus, it is
possible that some of the effects of PGE2 could have been
through an indirect effect on another cell type (such as ICCs,
urothelial cells or Schwann cells) releasing a paracrine factor,
or coupling through gap junctions, which influenced SMCs
(rather than the nerves). However, while there is strong evi-
dence of active calcium transients and electrical activity in
ICCs, these are not temporally coupled with either contrac-
tion of the smooth muscle, smooth muscle Ca2+ activity or
smooth muscle electrical activity (Hashitani et al., 2004b).
Therefore, at the current time the involvement of ICCs is
speculative.
ICCs may also act as a source of PGE2, as they are known
to release PGs in the urogenital tract under some conditions
(Hashitani, 2006). This may mediate urothelial to SMC
signalling.
Implications of this study
PGE2 is thought to play a role in bladder overactivity. In situ,
the bladder’s afferent nerves can stimulate spinal cord-
mediated reflexes through C-fibre afferent nerves; PGs could
act as neuromodulators to induce this excitability and
bladder overactivity, for example in the case of spinal cord
injury (Maggi et al., 1988).
Our experiments suggest that in addition to this reflex
pathway there is a direct local action of PGE2 in the bladder
that does not require an increase in cholinergic or purinergic
parasympathetic activation. It is known that EP1 KO mice do
not develop bladder hyperactivity after bladder outlet
obstruction but that WTmice do (Schröder et al., 2004), high-
lighting the importance of prostanoid signalling for the
pathogenesis of bladder overactivity.
Thus, we confirmed that PGE2 (50 mM) increases smooth
muscle activity in mouse bladder strips in vitro, as seen in
other species (Maggi et al., 1988). This was seen as an increase
in phasic contraction, mediated by SMC depolarization and
L-type Ca2+ channel-dependent action potentials (observed
with both electrophysiology and Ca2+ imaging). Our studies
also demonstrated that more than one EP receptor subtype
can generate such spontaneous activity. Depolarization,
rather than a fall in gap junction resistance, increases the
functional coupling of SMCs. While the effects of prostanoids
on afferent C-fibres are undoubtedly important, the direct
effects of PGE2 on the isolated bladder (which do not require
neurotransmitter release from the efferent parasympathetic
nerves) implies that rational therapies for such overactivity
should not focus solely on the spinal cord reflex arc, but
should also prevent PG’s direct action on bladder smooth
muscle. These muscle-mediated effects could produce the
detrusor overactivity that follows outlet obstruction and
spinal cord injury, which are both associated with increases
in PGE2 production (Masick et al., 2001; Masunaga et al.,
2006).
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Supporting information
Additional Supporting Information may be found in the
online version of this article:
Figure S1 In addition to the effects on WCTs, PGE2 appeared
to increase the frequency of subcellular Ca2+ transients,
including waves. Some of these subcellular Ca2+ transients
also appear to be periodic. A control series of recordings and
a subsequent recording from the same field of view in the
presence of PGE2 (50 mM) are shown. The scale bar represents
5 mm; for display purposes this movie plays at twice the
sampling rate.
Figure S2 PGE2-induced coupled WCTs in smooth muscle
cells. A series of confocal images showing WCTs temporally
synchronized in neighbouring cells – those shown in
Figure 8A. Each frame is 50 mm across; for display purposes
this movie plays at twice the sampling rate.
Figure S3 Labelling of spindle-shaped cells reminiscent of
ICCs. In most experiments, only smooth muscle (sm) cells
were identified; in some experimental series, spindle-shaped
cells reminiscent of ICCs, Schwann cells or fibroblasts (IC?)
could be identified, brightly labelled with the Ca2+ indicator.
To date, such cells have been unresponsive to physiological
stimuli. The field size is 100 mm.
Please note: Wiley-Blackwell are not responsible for the
content or functionality of any supporting materials supplied
by the authors. Any queries (other than missing material)
should be directed to the corresponding author for the article.
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